Lifecore Biomedical, Inc. De (LFCR) Total Current Liabilities (2011 - 2025)

Lifecore Biomedical has reported Total Current Liabilities for 15 years, with the latest figure at $30.2 million in Q2 2025.

• On a quarterly basis, Total Current Liabilities fell 22.37% year-over-year to $30.2 million in Q2 2025; TTM through May 2025 was $30.2 million, a 22.37% decrease from a year earlier, with the FY2025 full-year figure at $30.2 million, down 22.37% from the prior year.
• Total Current Liabilities was $30.2 million for Q2 2025 at Lifecore Biomedical, down from $31.1 million in the prior quarter.
• The five-year high for Total Current Liabilities was $195.6 million in Q4 2022, with the low at $30.2 million in Q2 2025.
• Average Total Current Liabilities over 5 years is $81.1 million, with a median of $40.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities soared 73.37% in 2022, then sank 80.19% in 2023.
• Over 5 years, Total Current Liabilities stood at $122.4 million in 2021, then soared by 59.83% to $195.6 million in 2022, then slumped by 79.42% to $40.3 million in 2023, then decreased by 12.33% to $35.3 million in 2024, then fell by 14.49% to $30.2 million in 2025.
• The last three Total Current Liabilities figures came in at $30.2 million (Q2 2025), $31.1 million (Q1 2025), and $35.3 million (Q4 2024), per Business Quant data.